2,4-Pyrimidinediamine, N4-(1H-pyrazol-3-ylmethyl)-N2-(1,2,3,4-tetrahydro-2-methyl-6-isoquinolinyl)-5-(trifluoromethyl)-;PCC-0208017,PCC0208017;PCC0208017, 10 mM in DMSO
标准英文名
PCC0208017
分子式
C14H17BrNO3PS
分子量
403.41
精确分子量
388.99
SMILES
S=P(OCC)(O/C(C1=CC=CC=C1)=C(C#N)/CBr)OCC
标准SMILES
CCOP(=S)(O/C(=C(/CBr)\C#N)/C1C=CC=CC=1)OCC
用途
PCC0208017 is a potent inhibitor of microtubule affinity-regulating kinases MARK3 and MARK4, with IC50 values of 1.8 and 2.01 nM, respectively; it exhibits significantly weaker inhibition against MARK1 and MARK2 (IC50 = 31.4 and 33.7 nM). It suppresses glioma progression both in vitro and in vivo, disrupts microtubule dynamics, induces G2/M cell cycle arrest and apoptosis, and demonstrates potent antitumor activity with good blood-brain barrier (BBB) permeability.